Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Vitreous Penetration of Orally Administered Famciclovir
American Journal of Ophthalmology, 06/26/09
Chong DY et al. - Oral administration of famciclovir results in vitreous concentrations of penciclovir within the inhibitory ranges for herpes simplex 1, herpes simplex 2, and varicella zoster virus. Oral famciclovir may be a reasonable alternative to intravenous acyclovir in the treatment of acute retinal necrosis, especially in cases of acyclovir resistance or patient inability to tolerate prolonged intravenous treatment.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Patients' preferences for positioning during phaco-emulsification under topical-intracameral anaesthesia
Clinical and Experimental Ophthalmology, 10/13/09
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
Eye, 10/06/09
Article Search
Sponsor


See Latest Articles


